The synthesized MOF is then unlocked in cancer cells in response to high intracellular glutathione (GSH) to release porphyrin-NLS and PPE, which proteolytically liberates the CD95 DD in cytosol, causing moderate histone H1 translocation50,51. Here, H1-0 is linked to cancer.